With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
On Thursday April 7, 2005 - World Health Day - CGD launched a report with the potential to save millions of lives. Making Markets for Vaccines: Ideas to Action presents an achievable approach to creating incentives for pharmaceutical and biotechnology manufacturers in the rich world to invest in the research and development of vaccines for diseases that mostly affect the poor world.
The event featured speakers from the CGD working group that created the report, representing top intellectuals from the legal, health and development communities. Attendance for the launch topped 150 people and generated press from several major news sources including the Wall Street Journal.
Nancy Birdsall - President, Center for Global Development Peter Hutt - Senior Counsel, Covington & Burling
Mark Feinberg - Vice President for Policy, Public Health, and Medical Affairs, Merck & Co., Inc Rick Klausner - Executive Director, Global Health, Bill & Melinda Gates Foundation Scott Whitaker - Executive Vice President, Biotech Industry Organization
Presentation of the Report:
John Hurvitz - Partner, Covington & Burling Ruth Levine - Director of Programs and Senior Fellow, Center for Global Development
Alice Albright - CFO, Vaccine Fund Rudi Daems - Executive Director, Policy and Corporate Affairs, Chiron Corp. Michael Kremer - Professor, Harvard University Orin Levine - Executive Director, Pneumo ADIP Melinda Moree - Director, Malaria Vaccine Initiative, PATH